Institutional Investors Negative on on Parexel International Corp Falls

October 12, 2017 - By Henry Gaston

 Institutional Investors  Negative on on Parexel International Corp  Falls

Sentiment for Parexel International Corp (NASDAQ:PRXL)

Parexel International Corp (NASDAQ:PRXL) institutional sentiment decreased to 0.75 in Q2 2017. Its down -0.19, from 0.94 in 2017Q1. The ratio fall, as 128 hedge funds increased and started new holdings, while 170 sold and reduced their stakes in Parexel International Corp. The hedge funds in our partner’s database now have: 40.76 million shares, down from 47.35 million shares in 2017Q1. Also, the number of hedge funds holding Parexel International Corp in their top 10 holdings increased from 0 to 6 for an increase of 6. Sold All: 49 Reduced: 121 Increased: 67 New Position: 61.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has market cap of $. The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries. It currently has negative earnings. The Company’s divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI).

It is down 35.35% since October 12, 2016 and is uptrending. It has outperformed by 18.65% the S&P500.

Analysts expect PAREXEL International Corporation (NASDAQ:PRXL) to report $0.89 EPS on October, 25.They anticipate $0.13 EPS change or 17.11 % from last quarter’s $0.76 EPS. After having $1.02 EPS previously, PAREXEL International Corporation’s analysts see -12.75 % EPS growth.

Glazer Capital Llc holds 4.47% of its portfolio in PAREXEL International Corporation for 807,043 shares. Water Island Capital Llc owns 1.06 million shares or 4.34% of their US portfolio. Moreover, Omni Partners Llp has 3.32% invested in the company for 298,030 shares. The New York-based Kellner Capital Llc has invested 2.45% in the stock. Twin Securities Inc., a New York-based fund reported 175,000 shares.#img1#

PAREXEL International Corporation (NASDAQ:PRXL) Ratings Coverage

Ratings analysis reveals 6% of Parexel International’s analysts are positive. Out of 17 Wall Street analysts rating Parexel International, 1 give it “Buy”, 3 “Sell” rating, while 13 recommend “Hold”. The lowest target is $49 while the high is $88.1000. The stock’s average target of $70.64 is 0.00% above today’s ($0) share price. PRXL was included in 38 notes of analysts from August 7, 2015. As per Friday, February 3, the company rating was downgraded by Deutsche Bank. The company was downgraded on Thursday, November 17 by First Analysis. The rating was downgraded by Avondale to “Mkt Underperform” on Monday, January 25. Deutsche Bank maintained the shares of PRXL in report on Friday, August 7 with “Hold” rating. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has “Market Perform” rating given on Monday, July 18 by William Blair. The rating was maintained by Mizuho on Tuesday, May 30 with “Buy”. The firm has “Market Perform” rating by Avondale given on Wednesday, October 21. The firm earned “Underperform” rating on Monday, April 11 by Avondale. Evercore downgraded the stock to “Hold” rating in Tuesday, June 20 report. Credit Suisse downgraded the shares of PRXL in report on Monday, February 6 to “Neutral” rating.

More news for PAREXEL International Corporation (NASDAQ:PRXL) were recently published by: Businesswire.com, which released: “PAREXEL International Receives Shareholder Approval for Proposed Acquisition …” on September 18, 2017. Pehub.com‘s article titled: “Pamplona completes take-private acquisition of Parexel” and published on October 02, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.